Skip Navigation

European Heart Journal 2001 22(21):2026-2028; doi:10.1053/euhj.2001.2814
Copyright © 2001 by the European Society of Cardiology.
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (3)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Batchelor, W.B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Batchelor, W.B.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Letters to the Editor

From COURT to HOMBURG: in search of the optimal contrast agent

W.B. Batchelor

Terrence Donnelly Heart Centre, St. Michael's Hospital, Toronto, Ontario, Canada

References

  1. Scheller B, Hennen B, Pohl A, Schieffler H, Markwirth T. Acute and subacute stent occlusion;risk-reduction by ionic contrast media. Eur Heart J. 2001;22:385–391[Abstract/Free Full Text]
  2. Davidson CJ, Laskey WK, Hermiller JB. Randomized trial of contrast media utilization in high-risk PTCA: the COURT trial. Circulation. 2000;101:2172–2177[Abstract/Free Full Text]
  3. Idée JM, Corot C. Thrombotic risk associated with the use of iodinated contrast media in interventional cardiology: pathophysiology and clinical aspects. Fundam Clin Pharmacol. 1999;13:613–623[Web of Science][Medline]
  4. Li X, Gabriel DA. Differences between contrast media in the inhibition of platelet activation by specific platelet agonists. Acad Radiol. 1997;4:108–114[CrossRef][Web of Science][Medline]
  5. Heptinstall S, White A, Edwards N. Differential effects of three radiographic contrast media on platelet aggregation and degranulation: implications for clinical practice? Br J Haematol. 1998;103:1023–1030[CrossRef][Web of Science][Medline]
  6. Chronos NA, Goodall AH, Wilson DJ, Sigwart U, Buller NP. Profound platelet degranulation is an important side effect of some types of contrast media used in interventional cardiology [see comments]. Circulation. 1993;88:2035–2044[Abstract/Free Full Text]
  7. Dehmer GJ, Gresalfi N, Daly D. Impairment of fibrinolysis by streptokinase, urokinase and recombinant tissue-type plasminogen activator in the presence of radiographic contrast agents. J Am Coll Cardiol. 1995;25:1069–1075[Abstract]
  8. Corot C, Chronos N, Sabattier V. In vitro comparison of the effects of contrast media on coagulation and platelet activation. Blood Coagul Fibrinolysis. 1996;7:602–608[Web of Science][Medline]
  9. Limbruno U, Petronio AS, Amoroso G. The impact of coronary artery disease on the coronary vasomotor response to nonionic contrast media. Circulation. 2000;101:491–497[Abstract/Free Full Text]
  10. Grabowski EF, Jang IK, Gold H, Head C, Benoit SE, Michelson AD. Variability of platelet degranulation by different contrast media. Acad Radiol. 1996;3:S485–487
  11. Holmes DR Jr., Simpson JB, Berdan LG. Abrupt closure: the CAVEAT I experience. Coronary Angioplasty Versus Excisional Atherectomy Trial. J Am Coll Cardiol. 1995;260:1494–1500[CrossRef]
  12. Liss P, Nygren A, Olsson U. Effects of contrast media and mannitol on renal medullary blood flow and red cell aggregation in the rat kidney. Kidney Int. 1996;49:1268–1275[Web of Science][Medline]
  13. Sutton A, Grech E, Campbell P. Minimizing Contrast Reactions Following Cardiac Catheterization. Am J Cardiol. 1999;:
  14. Pohly J. Onset of late adverse drug reactions to dimeric non-ionic contrast media: iotrolan, iodixanol. Pharmacoepidemiology and Drug Safety. 1998;7:S18–S22
  15. Al Dieri R, Béguin S, Hemker HC. Anticoagulant- and antiplatelet-effect of an iodinated contrast medium, but not of a nonionic one. Am J Cardiol. 2000;86:100i

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Eur Heart JHome page
B. Scheller
A reply
Eur. Heart J., January 2, 2002; 23(2): 173 - 175.
[Full Text] [PDF]

Home page
 Eur Heart JHome page
B. Scheller
A reply
Eur. Heart J., January 2, 2002; 23(2): 176 - 177.
[Full Text] [PDF]

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (3)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Batchelor, W.B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Batchelor, W.B.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?